NEWS
Armitage readies healthtech for sale by tapping Houlihan Lokey

SYDNEY: Boutique investment firm Armitage Associates is ready to take the market’s pulse on its… read more
No chill pill for Pfizer over PBS as row erupts

CANBERRA: Multinational conglomerate Pfizer has accused the Pharmaceutical Benefits Scheme of “undervaluing” medical products in… read more
First sales data fires up shares in Mesoblast Group

MELBOURNE: Biotech Mesoblast has reported strong initial sales of its cell therapy, Ryoncil, its first… read more